$12.47
0.24[1.96%]
Last update: 12:29PM Get Real Time Here
NovoCure reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of NovoCure using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
07/25/2024 | AM | NVCR | Q2 | -$0.54 | — | — | — | $126.05M | — | — | — | Get Alert |
05/02/2024 | AM | NVCR | Q1 | -$0.50 | -$0.42 | — | — | $122.18M | $131.45M | — | — | Get Alert |
02/22/2024 | AM | NVCR | Q4 | -$0.36 | -$0.52 | -$0.45 | 13.46% | $128.43M | $131.19M | $133.78M | 1.98% | Get Alert |
10/26/2023 | AM | NVCR | Q3 | -$0.25 | -$0.52 | -$0.46 | 11.54% | $131.00M | $128.76M | $127.32M | -1.12% | Get Alert |
07/27/2023 | AM | NVCR | Q2 | -$0.23 | -$0.50 | -$0.54 | -8.00% | $140.87M | $124.26M | $126.05M | 1.44% | Get Alert |
05/04/2023 | AM | NVCR | Q1 | -$0.04 | -$0.32 | -$0.50 | -56.25% | $137.55M | $127.28M | $122.18M | -4.01% | Get Alert |
02/23/2023 | AM | NVCR | Q4 | -$0.25 | -$0.30 | -$0.36 | -20.00% | $133.21M | $128.25M | $128.43M | 0.14% | Get Alert |
10/27/2022 | AM | NVCR | Q3 | -$0.13 | -$0.26 | -$0.25 | 3.85% | $133.61M | $131.94M | $131.00M | -0.71% | Get Alert |
07/28/2022 | AM | NVCR | Q2 | -$0.14 | -$0.15 | -$0.23 | -53.33% | $133.52M | $134.99M | $140.87M | 4.35% | Get Alert |
04/28/2022 | AM | NVCR | Q1 | -$0.04 | -$0.18 | -$0.04 | 77.78% | $134.69M | $134.08M | $137.55M | 2.59% | Get Alert |
02/24/2022 | AM | NVCR | Q4 | $0.04 | -$0.10 | -$0.25 | -150.00% | $143.95M | $135.42M | $133.21M | -1.63% | Get Alert |
10/28/2021 | AM | NVCR | Q3 | $0.09 | -$0.07 | -$0.13 | -85.71% | $132.66M | $141.76M | $133.61M | -5.75% | Get Alert |
07/29/2021 | AM | NVCR | Q2 | $0.02 | $0.01 | -$0.14 | -1500.00% | $115.92M | $141.89M | $133.52M | -5.90% | Get Alert |
04/29/2021 | AM | NVCR | Q1 | $0.04 | $0.02 | -$0.04 | -300.00% | $101.83M | $139.36M | $134.69M | -3.35% | Get Alert |
02/25/2021 | AM | NVCR | Q4 | $0.04 | $0.12 | $0.04 | -66.67% | $99.23M | $141.29M | $143.95M | 1.88% | Get Alert |
10/29/2020 | AM | NVCR | Q3 | $0.02 | $0.03 | $0.09 | 200.00% | $92.06M | $120.24M | $132.66M | 10.33% | Get Alert |
07/30/2020 | AM | NVCR | Q2 | -$0.01 | — | $0.02 | — | $86.71M | $106.03M | $115.92M | 9.33% | Get Alert |
04/30/2020 | AM | NVCR | Q1 | -$0.13 | $0.02 | $0.04 | 100.00% | $73.31M | $102.15M | $101.83M | -0.32% | Get Alert |
02/27/2020 | AM | NVCR | Q4 | -$0.17 | $0.02 | $0.04 | 100.00% | $69.67M | $95.65M | $99.23M | 3.75% | Get Alert |
NovoCure (NVCR) is scheduled to report earnings on July 25, 2024. The last reported earnings were for reported on February 22, 2024 for Q4.
The Actual EPS was $-0.45, which beat the estimate of $-0.52.
The Actual Revenue was $133.8M, which beat the estimate of $131.2M.
Browse earnings estimates, EPS, and revenue on all stocks.